GemPharmatech Co., Ltd. (SHA:688046)
China
· Delayed Price · Currency is CNY 20.66
+0.20 (0.98%)
At close: Apr 29, 2026
GemPharmatech Revenue
GemPharmatech had revenue of 208.08M CNY in the quarter ending March 31, 2026, with 21.79% growth. This brings the company's revenue in the last twelve months to 830.61M, up 18.56% year-over-year. In the year 2025, GemPharmatech had annual revenue of 793.39M with 15.51% growth.
Revenue (ttm)
830.61M
Revenue Growth
+18.56%
P/S Ratio
10.10
Revenue / Employee
526.37K
Employees
1,578
Market Cap
8.39B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Ausun Pharmaceutical | 792.76M |
| Youcare Pharmaceutical Group | 2.45B |
| Sino Biological,Inc. | 699.56M |
| Daan Gene | 757.66M |
| Bio-Thera Solutions | 935.22M |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 1.84B |
| Shanghai Medicilon | 1.16B |
| Nanjing Vazyme Biotech | 1.41B |